Fidelman Nicholas, Allen Derrick, Bloom Allan I, LaBerge Jeanne M, Hastings Geoffrey S, Kerlan Robert K, Gordon Roy L, Wilson Mark W
Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Rm M-361, San Francisco, CA 94143, USA.
J Vasc Interv Radiol. 2007 May;18(5):597-601. doi: 10.1016/j.jvir.2007.02.017.
To describe clinical outcomes of endovascular interventions in the setting of thrombosis or dysfunction of anterior chest wall ("necklace") arteriovenous (AV) hemodialysis grafts.
Eight percutaneous interventions (balloon angioplasty, pharmacologic thrombolysis, and mechanical thrombectomy) were performed in five patients with anterior chest wall AV grafts. Primary, assisted, and secondary patencies, as well as technical success and complication rates, were determined.
The technical success rate of percutaneous interventions in re-establishing a normal blood flow pattern within the AV grafts was 100%. Primary patency ranged from one to 23 months (median, 5 months). Primary assisted patency and secondary patency were 36 months and 8 months, respectively, in two patients who underwent more than one intervention. Postintervention access patency ranged from 5 to 36 months (median, 9 months), whereas graft lifetime ranged from 12 to 45 months (median, 24 months). There were no complications related to revascularization procedures.
Percutaneous interventions can be performed safely and effectively in anterior chest wall AV grafts. Technical success and long-term patency rates appear to be similar to those of percutaneous interventions in upper-extremity hemodialysis AV grafts.
描述在前胸壁(“项链”)动静脉(AV)血液透析移植物发生血栓形成或功能障碍的情况下,血管内介入治疗的临床结果。
对5例前胸壁AV移植物患者进行了8次经皮介入治疗(球囊血管成形术、药物溶栓和机械血栓切除术)。确定了初次通畅率、辅助通畅率和二次通畅率,以及技术成功率和并发症发生率。
经皮介入治疗在重建AV移植物内正常血流模式方面的技术成功率为100%。初次通畅时间为1至23个月(中位数为5个月)。在接受不止一次介入治疗的2例患者中,初次辅助通畅时间和二次通畅时间分别为36个月和8个月。介入治疗后通路通畅时间为5至36个月(中位数为9个月),而移植物使用寿命为12至45个月(中位数为24个月)。没有与血运重建手术相关的并发症。
经皮介入治疗在前胸壁AV移植物中可以安全有效地进行。技术成功率和长期通畅率似乎与上肢血液透析AV移植物的经皮介入治疗相似。